Peking University Institute of Hematology

The Peking University Institute of Hematology is a comprehensive center for the diagnosis and treatment of hematologic diseases and has established the standard diagnostic and therapeutic system for hematologic malignancies. It is also a National Key Discipline of the Ministry of Education, an Innovative Group of the Ministry of Education, and a Clinical Key Discipline of the National Health Commission. Additionally, the institute is home to one of the five largest hematopoietic stem cell transplantation centers in the world and the largest in Asia.

In 1964, the institute performed the fourth syngeneic bone marrow transplantation in the world and the first in Asia. In 1981, the institute took the lead in carrying out HLA-matched sibling allogeneic bone marrow transplantation in China. After decades of hard work, the Peking University Institute of Hematology became the first to establish an HLA-mismatched hematopoietic stem cell transplantation system in the world. Today, approximately 700 cases of hematopoietic stem cell transplantation are performed annually at the institute, with more than 5,000 cases completed to date.

The institute currently employs 430 staff members, including doctors, nurses, and research scientists, with 15 professors and 24 associate professors. It has 370 beds, including 80 beds in a laminar flow ward for bone marrow transplantation, and 20 research laboratories, covering over 2,000 square meters of floor space. The institute has undertaken more than 20 national and ministerial/provincial projects, including the National High-tech Research and Development Program (863 Program). It has been awarded the Second Prize of the National Science and Technology Progress Award, as well as first and second ministerial/provincial prizes more than five times. Total research funding exceeds 60 million CNY, and the value of research instruments is over 7 million CNY, including more than 10 instruments valued at over 100,000 CNY each.